Fmoc-D-cyclohexylalanine

Fmoc-D-cyclohexylalanine is an Fmoc-protected D-amino acid in which the stereogenic center is configured as D and the side chain is a cyclohexyl group, giving a bulky, hydrophobic aliphatic handle for peptide and peptidomimetic design. The molecule contains the Fmoc carbamate on the α-amino function and a carboxylic acid moiety, enabling controlled participation in amide bond formation while remaining compatible with orthogonal protection strategies. The cyclohexyl side chain can influence conformational preferences and hydrophobic packing in peptide backbones, while the Fmoc group supports standard base-labile deprotection during solid-phase or solution-phase synthesis. As a chiral amino acid building block, Fmoc-D-cyclohexylalanine functions as a stereochemically defined intermediate for downstream derivatization, peptide coupling chemistry, and structure-guided synthetic studies.

1. Peptide Synthesis

Fmoc-D-cyclohexylalanine is applied in peptide synthesis workflows where Fmoc protection enables stepwise N-terminal deprotection and subsequent coupling to activated carboxylic acids or peptide fragments. The D-configuration at the α-carbon provides stereochemical control that can be incorporated into peptide sequences to modulate backbone geometry, protease stability, and side-chain packing. The cyclohexyl side chain serves as a hydrophobic residue analog that can be used to tune folding propensity and receptor-contact surfaces in peptide libraries. The carboxylic acid functionality participates in standard amide bond formation, making the compound suitable for generating defined D-amino acid-containing peptides and peptide analogs for research-grade scaffold construction.

2. Peptidomimetics And SAR Studies

Fmoc-D-cyclohexylalanine is relevant to peptidomimetic construction and structure-activity relationship studies because its cyclohexyl side chain provides a rigid, bulky hydrophobic element distinct from linear alkyl amino acids. The D-amino acid stereochemistry can be leveraged to probe how inversion of configuration affects conformational ensembles and binding-site complementarity in SAR campaigns. The Fmoc-protected amine supports incorporation into larger synthetic sequences, enabling systematic variation of residue identity while maintaining consistent coupling behavior. Downstream, the resulting D-cyclohexylalanine-containing analogs can be used as comparative fragments in medicinal chemistry design, fragment-to-lead optimization, and mechanistic studies of molecular recognition.

3. Side-Chain Functionalization

Fmoc-D-cyclohexylalanine is utilized for side-chain functionalization strategies in synthetic organic chemistry where the cyclohexyl group can be transformed into more reactive or more polar substituents through targeted derivatization routes. The protected α-amine and free carboxylic acid allow orthogonal handling: Fmoc chemistry can be used to control peptide compatibility, while the side chain can be modified to introduce functional groups that enable further conjugation or receptor-interaction tuning. The stereodefined D-center helps maintain configurational integrity during multi-step sequences that generate functionalized amino acid derivatives or intermediate fragments. The resulting derivatives can serve as building blocks for chemical biology probes, linker-bearing amino acids, and intermediate preparation for complex molecule synthesis.

4. Chemical Biology Probes

Fmoc-D-cyclohexylalanine is suitable for chemical biology research and biomolecular interaction mapping where incorporation of D-amino acid residues supports probe stability and defined hydrophobic character. The Fmoc-protected amine supports controlled synthesis of labeled or functionalized peptide probes, while the cyclohexyl side chain can enhance membrane association or hydrophobic binding interactions in target engagement studies. The stereochemical purity of the D-amino acid helps ensure that observed binding or labeling behavior correlates with sequence-defined structure rather than stereochemical heterogeneity. Downstream, the compound can be incorporated into peptide-based probes that undergo further functionalization for imaging, affinity capture, or crosslinking chemistry depending on the chosen labeling handle.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-D-cyclohexylalanine is relevant to pharmaceutical manufacturing and fine chemical synthesis as a chiral, protected amino acid intermediate for producing D-amino acid-containing peptide intermediates under controlled synthetic sequences. The Fmoc carbamate provides a robust protection strategy for the α-amino group during upstream processing, while the carboxylic acid enables predictable activation and coupling steps in peptide fragment assembly. The cyclohexyl side chain contributes hydrophobic residue character that may be required for specific peptide architectures used in manufacturing pipelines for research and development materials. The compound's defined stereochemistry and protection pattern support reproducible intermediate generation for downstream peptide construction, purification workflows, and scalable synthesis planning.

6. Analytical Research Standards

Fmoc-D-cyclohexylalanine is employed in analytical research contexts as a stereochemically defined reference material for method development and characterization of Fmoc-based peptide intermediates. The combination of Fmoc protection and a D-configured cyclohexylalanine core enables unambiguous tracking of amino acid incorporation, deprotection events, and residue identity in LC-MS or related analytical workflows. The distinct hydrophobic cyclohexyl side chain can improve chromatographic differentiation from other aliphatic amino acids, supporting reliable peak assignment for complex peptide mixtures. The compound can also serve as a starting point for generating labeled or derivatized standards that support analytical verification of peptide building blocks and stereochemical integrity during peptide synthesis development.

1. The spatiotemporal control of signalling and trafficking of the GLP-1R

2. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore

3. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

4. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes